We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ADOC market cap is 118.5M. The company's latest EPS is EUR -0.4898 and P/E is -17.17.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 53.93M | 8.14M | 6.83M | 6.06M | 28.56M |
| Operating Income | 9.71M | -22.02M | -21.15M | -19.22M | -1.68M |
| Net Income | 7.62M | -18.6M | -23.32M | -22.75M | -6.9M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 70.04M | 61.95M | 45.17M | 30.05M | 30.61M |
| Total Liabilities | 24.2M | 33.91M | 38.83M | 43.87M | 43.58M |
| Total Equity | 45.85M | 28.04M | 6.33M | -13.82M | -12.97M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 6.31M | -9.66M | -21.85M | -19.24M | -15M |
| Investing | -1.03M | -2.05M | -205k | -361k | 21.86M |
| Financing | -216k | 15.53M | 6.51M | 6.65M | -4.61M |
| Market Cap | 118.5M |
| Price to Earnings Ratio | -17.17 |
| Price to Sales Ratio | 4.15 |
| Price to Cash Ratio | 6.8 |
| Price to Book Ratio | -9.14 |
| Dividend Yield | - |
| Shares Outstanding | 14.09M |
| Average Volume (1 week) | 68.69k |
| Average Volume (1 Month) | 86.79k |
| 52 Week Change | 192.52% |
| 52 Week High | 16.16 |
| 52 Week Low | 2.765 |
| Spread (Intraday) | 0.12 (1.42%) |
| Company Name | Adocia |
| Address |
115 avenue lacassagne lyon, rhone 69003 |
| Website | https://www.adocia.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
